Infectious Disease
NIH commences tuberculous meningitis drug combination regimen trial
The US National Institutes of Health (NIH) has commenced the Phase II IMAGINE-TBM clinical trial of a new drug combination…
Viriom outlines plans for upcoming infectious disease trials
Viriom plans to extend a Phase I trial investigating its influenza pill AV5124, according to chief science officer Dr David…
World AIDS Day 2023 highlights community leadership to end the HIV epidemic
1 December commemorates World AIDS Day – a day of awareness and support for those living with HIV/AIDS, as well…
Merck reports data from Phase III pneumococcal vaccine trial
Merck (MSD) has reported data from the Phase III STRIDE-3 clinical trial of its investigational 21-valent pneumococcal conjugate vaccine, V116, for usage…
Vaxxas reports positive data from MR vaccine trial
Vaxxas has reported positive results from a Phase I clinical trial for the measles and rubella (MR) vaccine, which was…
Medicure approved to enrol patients in paediatric disease trial
Canadian pharmaceutical company Medicure has received full approval from the US Food and Drug Administration (FDA) to enrol subjects in…
Berlin Cures announces expansion of long Covid drug study
Swiss biopharmaceutical company Berlin Cures has announced the expansion of the Phase II clinical trial of its long Covid drug…
University of Queensland’s vaccine shows virus-neutralising effect in trial
The University of Queensland (UQ) in Australia has reported that its second-generation clamp vaccine demonstrated to be safe and possesses…
AIM ImmunoTech concludes dosing in Phase II post-Covid drug trial
AIM ImmunoTech has concluded subject dosing in the Phase II clinical trial of its investigational drug, Ampligen, to treat individuals with post-Covid…
FDA grants IND approval for Senhwa’s trial of Silmitasertib
The US Food and Drug Administration (FDA) has granted approval for Senhwa Biosciences’ investigational new drug application (IND) to commence a Phase…
